The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Colitis, Ulcerative

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Colitis, Ulcerative


Psychiatry related information on Colitis, Ulcerative


High impact information on Colitis, Ulcerative


Chemical compound and disease context of Colitis, Ulcerative


Biological context of Colitis, Ulcerative


Anatomical context of Colitis, Ulcerative


Gene context of Colitis, Ulcerative


Analytical, diagnostic and therapeutic context of Colitis, Ulcerative


  1. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. Klotz, U., Maier, K., Fischer, C., Heinkel, K. N. Engl. J. Med. (1980) [Pubmed]
  2. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S., Strober, W. Immunity (2002) [Pubmed]
  3. Disseminated varicella complicating ulcerative colitis. Keene, J.K., Lowe, D.K., Grosfeld, J.L., Fitzgerald, J.F., Gonzales-Crussi, F. JAMA (1978) [Pubmed]
  4. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. Campbell, B.J., Finnie, I.A., Hounsell, E.F., Rhodes, J.M. J. Clin. Invest. (1995) [Pubmed]
  5. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. Vaughan, J.H., Nguyen, M.D., Valbracht, J.R., Patrick, K., Rhodes, G.H. J. Clin. Invest. (1995) [Pubmed]
  6. Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis. Rao, S.S., Read, N.W., Stobart, J.A., Haynes, W.G., Benjamin, S., Holdsworth, C.D. Gut (1988) [Pubmed]
  7. Concept of alexithymia. I. The prevalence of alexithymia in psychosomatic patients. Keltikangas-Järvinen, L. Psychotherapy and psychosomatics. (1985) [Pubmed]
  8. Society for Research on Nicotine and Tobacco. Perkins, K.A., Benowitz, N., Henningfield, J., Newhouse, P., Pomerleau, O., Swan, G. Addiction (1996) [Pubmed]
  9. The therapeutic potential of nicotine and nicotinic agonists for weight control. Gurwitz, D. Expert opinion on investigational drugs. (1999) [Pubmed]
  10. Ulcerative colitis precipitated by a verocytotoxin-producing Escherichia coli infection. Farina, C., Caprioli, A., Luzzi, I., Sonzogni, A., Goglio, A. The Italian journal of gastroenterology. (1995) [Pubmed]
  11. Cyclosporine in severe ulcerative colitis. Vincent, F., Bensousan, T.A. N. Engl. J. Med. (1995) [Pubmed]
  12. Transdermal nicotine as maintenance therapy for ulcerative colitis. Thomas, G.A., Rhodes, J., Mani, V., Williams, G.T., Newcombe, R.G., Russell, M.A., Feyerabend, C. N. Engl. J. Med. (1995) [Pubmed]
  13. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. Lichtiger, S., Present, D.H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., Hanauer, S. N. Engl. J. Med. (1994) [Pubmed]
  14. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. Schroeder, K.W., Tremaine, W.J., Ilstrup, D.M. N. Engl. J. Med. (1987) [Pubmed]
  15. Sulfasalazine and salicylate-induced exacerbation of ulcerative colitis. Shanahan, F., Targan, S. N. Engl. J. Med. (1987) [Pubmed]
  16. Sulfasalazine-induced exacerbation of ulcerative colitis. Schwartz, A.G., Targan, S.R., Saxon, A., Weinstein, W.M. N. Engl. J. Med. (1982) [Pubmed]
  17. Transdermal nicotine for active ulcerative colitis. Pullan, R.D., Rhodes, J., Ganesh, S., Mani, V., Morris, J.S., Williams, G.T., Newcombe, R.G., Russell, M.A., Feyerabend, C., Thomas, G.A. N. Engl. J. Med. (1994) [Pubmed]
  18. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. Hofseth, L.J., Khan, M.A., Ambrose, M., Nikolayeva, O., Xu-Welliver, M., Kartalou, M., Hussain, S.P., Roth, R.B., Zhou, X., Mechanic, L.E., Zurer, I., Rotter, V., Samson, L.D., Harris, C.C. J. Clin. Invest. (2003) [Pubmed]
  19. A controlled trial of azathioprine in the management of chronic ulcerative colitis. Rosenberg, J.L., Wall, A.J., Levin, B., Binder, H.J., Kirsner, J.B. Gastroenterology (1975) [Pubmed]
  20. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Satsangi, J., Welsh, K.I., Bunce, M., Julier, C., Farrant, J.M., Bell, J.I., Jewell, D.P. Lancet (1996) [Pubmed]
  21. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Hampe, J., Cuthbert, A., Croucher, P.J., Mirza, M.M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A.J., Bridger, S., van Deventer, S., Forbes, A., Nikolaus, S., Lennard-Jones, J.E., Foelsch, U.R., Krawczak, M., Lewis, C., Schreiber, S., Mathew, C.G. Lancet (2001) [Pubmed]
  22. Increased nitric oxide synthesis in ulcerative colitis. Middleton, S.J., Shorthouse, M., Hunter, J.O. Lancet (1993) [Pubmed]
  23. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Carter, M.J., Di Giovine, F.S., Cox, A., Goodfellow, P., Jones, S., Shorthouse, A.J., Duff, G.W., Lobo, A.J. Gastroenterology (2001) [Pubmed]
  24. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Yin, J., Harpaz, N., Tong, Y., Huang, Y., Laurin, J., Greenwald, B.D., Hontanosas, M., Newkirk, C., Meltzer, S.J. Gastroenterology (1993) [Pubmed]
  25. Prospects for research in inflammatory bowel disease. Blumberg, R.S., Strober, W. JAMA (2001) [Pubmed]
  26. Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. Podolsky, D.K., Isselbacher, K.J. J. Clin. Invest. (1983) [Pubmed]
  27. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. Fuss, I.J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R.S., Mannon, P., Strober, W. J. Clin. Invest. (2004) [Pubmed]
  28. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Duerr, R.H., Targan, S.R., Landers, C.J., Sutherland, L.R., Shanahan, F. Gastroenterology (1991) [Pubmed]
  29. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Rosenberg, W.M., Prince, C., Kaklamanis, L., Fox, S.B., Jackson, D.G., Simmons, D.L., Chapman, R.W., Trowell, J.M., Jewell, D.P., Bell, J.I. Lancet (1995) [Pubmed]
  30. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. Watanabe, M., Ueno, Y., Yajima, T., Okamoto, S., Hayashi, T., Yamazaki, M., Iwao, Y., Ishii, H., Habu, S., Uehira, M., Nishimoto, H., Ishikawa, H., Hata, J., Hibi, T. J. Exp. Med. (1998) [Pubmed]
  31. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Newman, B., Gu, X., Wintle, R., Cescon, D., Yazdanpanah, M., Liu, X., Peltekova, V., Van Oene, M., Amos, C.I., Siminovitch, K.A. Gastroenterology (2005) [Pubmed]
  32. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Dubuquoy, L., Jansson, E.A., Deeb, S., Rakotobe, S., Karoui, M., Colombel, J.F., Auwerx, J., Pettersson, S., Desreumaux, P. Gastroenterology (2003) [Pubmed]
  33. Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa. Nakazawa, A., Watanabe, M., Kanai, T., Yajima, T., Yamazaki, M., Ogata, H., Ishii, H., Azuma, M., Hibi, T. Gastroenterology (1999) [Pubmed]
  34. Illuminating the role of type I IFNs in colitis. Wirtz, S., Neurath, M.F. J. Clin. Invest. (2005) [Pubmed]
  35. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Singer, I.I., Kawka, D.W., Schloemann, S., Tessner, T., Riehl, T., Stenson, W.F. Gastroenterology (1998) [Pubmed]
  36. Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study. Stein, D.T., Gray, G.M., Gregory, P.B., Anderson, M., Goodwin, D.A., McDougall, I.R. Gastroenterology (1983) [Pubmed]
  37. J-chain expression is more prominent in immunoglobulin A2 than in immunoglobulin A1 colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease. Kett, K., Brandtzaeg, P., Fausa, O. Gastroenterology (1988) [Pubmed]
WikiGenes - Universities